(Q84820431)
Statements
Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity (English)
Rindert de Vries
Jeroen J J van Leeuwen
L Joost van Pelt
Alexandros D Tselepis
Laurent Lagrost
Robin P F Dullaart